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Abstract
Vpu is an 81 amino acid auxiliary protein in HIV-1 which exhibits channel activity. We used two homo-pentameric bundles
with the helical transmembrane segments derived from FTIR spectroscopy in combination with a global molecular dynamics
search protocol : (i) tryptophans (W) pointing into the pore, and (ii) W facing the lipids. Two equivalent bundles have been
generated using a simulated annealing via a restrained molecular dynamics simulations (SA/MD) protocol. A fifth model was
generated via SA/MD with all serines facing the pore. The latter model adopts a very stable structure during the 2 ns of
simulation. The stability of the models with W facing the pore depends on the starting structure. A possible gating
mechanism is outlined. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
The genome of the enveloped virus HIV-1 encodes
a small auxiliary phosphoprotein with a length of
81 amino acids called Vpu [1,2]. It is composed of
a hydrophobic transmembrane (TM) domain (amino
acids 1^27, N-terminal end) and a hydrophilic cyto-
plasmic domain of 54 amino acids (C-terminal end)
[3]. Vpu is not found in the envelope of the virus
particle but is expressed to the membranes of sub-
cellular compartments of the infected cell [4]. Vpu
has two major roles in the life cycle of the virus:
(i) it controls the release/secretion of virus particles
from the cell surface [5,6], and (ii) it mediates the
degradation of the CD4 protein in the endoplasmic
reticulum (ER) [7,8]. The TM segment of Vpu is
responsible for particle release/secretion [9] whereas
the cytoplasmic site is essential for degradation of
CD4 protein [8^10].
There is reasonable, if not conclusive, evidence
that Vpu can form ion channels: Vpu expressed in
Escherichia coli, puri¢ed and reconstituted in planar
lipid bilayer shows channel activity [11], also a syn-
thetic peptide corresponding to the putative TM seg-
ment of Vpu exhibits channel activity [12,13]. How-
ever, ¢nal proof of channel activity with a channel
blocking agent is still lacking.
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NMR [13^17], CD [18], and FTIR spectroscopic
data [19,20] of the synthesized putative TM segments
of several channel peptides reveal a high helical con-
tent of the peptides reconstituted in lipid bilayers.
Also various secondary structure prediction methods
predict a single helical segment for all the viral ion
channel peptides which is consequently assumed to
span the bilayer [21]. Self-assembly is a characteristic
feature of Vpu in vivo as well as in vitro [3,22]. The
exact number of homo-oligomers which form the
channel is not yet known. Molecular modelling sim-
ulation studies suggest the formation of at least ¢ve
parallel helices to form an ion channel [23,24].
In recent experiments FTIR spectroscopy was used
to elucidate the orientation of the putative TM seg-
ment of Vpu (AIV A10 LVVAIIIAI V20 VWSIVIIE)
[19] in a lipid bilayer. Thereby speci¢c isotopic la-
belled (13C) amino acids were incorporated in the
TM segment. In combination with a global molecu-
lar dynamics (MD) search protocol the following
structural model is proposed [19]: a bundle consist-
ing of ¢ve identical segments (homo-pentamer) with
the tryptophan in each of the segments pointing into
the pore. We use this structure and perform a 2 ns
molecular modelling simulation in a fully hydrated
bilayer. We also investigate a bundle with all trypto-
phans facing the lipid phase from the same study
[19]. In comparison two similar structures, with re-
spect to the orientation of the tryptophans, are built
using a simulated annealing via restrained molecular
dynamics simulations (SA/MD) protocol [25,26]. An
additional structure is created by SA/MD with the
serine residues pointing into the pore. With this
study we aim to assess which of the bundles seems
to be an energetically stable structure.
2. Materials and methods:
2.1. Modelling
Bundles of Vpu segments derived from Arkin and
co-workers [19] are based on a FTIR spectroscopic
analysis on the orientation of the putative TM seg-
ment of Vpu (22 amino acids: AIV A10 LVVAIIIAI
V20 VWSIVIIE) reconstituted into vesicles. The anal-
ysis of the spectroscopic data leads to a helix tilt
angle (angle between membrane normal and helix
axis) of 6‡ and pitch angles (angle between two con-
secutive residues in an K-helix; gi1 = 100‡ for a stan-
dard K-helix) of gi7 = (283 þ 11)‡ for the 13C labels
Val13/Val20 and gi7 = (23 þ 11)‡ for the 13C labels
Ala14/Val21. A global MD search protocol without
any restraints on homo-tetra-, penta- and hexameric
bundles releases a set of 288 structures. A detailed
description of the data generation is given elsewhere
[19,27]. In brief, calculations are done with idealized
helices (rise/residue = 1.5 Aî ; 3.6 residues per turn) in
vacuo. Symmetric tetramers, pentamers and hexam-
ers (n = 4, 5, 6) are generated by replicating the helix
and rotating it by 360‡/n around the centre of the
bundle. An initial crossing angle of 25‡ for left-
handed and 325‡ for right-handed bundle is applied
by rotating the long helix axis with respect to the
long bundle axis. Rotations simultaneously to all
helices are carried out between 0‡ and 360‡ in steps
of 10‡. Using di¡erent initial random atom velocities
four trials with each starting structure are carried
out. This results in 36U4U2 = 288 structures. For
each structure a simulated annealing and energy min-
imization protocol is applied. Structures are clustered
(minimum of 10 structures) if the root mean square
deviation (RMSD) is 90.1 nm. For each cluster an
average structure is calculated, energy minimized and
used in the same simulated annealing protocol as
mentioned above.
The model with the pitch angle (gi7 = 316‡ (Val13)
and 55‡ (Ala14)) closest to the experimental
values (gi7 = 283‡ þ 11‡ and 23‡ þ 11‡; helix tilt
L= 6.5‡ þ 11‡), a homo-pentamer, is one of the ener-
getically most favourable bundles (W-in) (Table 1).
The second pentameric model is chosen so that all
tryptophans point towards the lipid phase (W-out).
We also generate three pentameric models using a
SA/MD protocol [25,26] based on the programme
Xplor [28], implementing a starting tilt angle of 5‡.
The SA/MD protocol comprises two stages: in stage
1 bundles of n (number of segments, here n = 5) par-
allel, idealized K-helices are constructed correspond-
ing to the CK atoms of the peptide unit. All other
atoms of the individual amino acids are superim-
posed. During stage 1 these other atoms ‘evolve’
from the CK atoms remaining ¢xed. Beginning the
annealing at 1000 K weights for bond length, bond
angles, planarity and chirality are gradually in-
creased. A repulsive van der Waals term is slowly
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introduced after an initial delay. After reaching the
¢nal scaling factors of these components of the em-
pirical energy function the bundle is cooled to 300 K,
in steps of 10 K per 0.5 ps. Van der Waals radii are
reduced to 80% during this stage. This allows the
atoms to pass each other. We obtain ¢ve structures
for each bundle. Each structure from stage 1 will be
used for ¢ve molecular dynamics runs in stage 2. In
stage 2 initial velocities correspond to 500 K. Har-
monic restraints hold the CK atoms, but are relaxed
as the temperature drops from 500 to 300 K. At this
stage distance restraints are also introduced. At
300 K a constant temperature dynamics for 5 ps is
performed, followed by a 1000 steps of conjugate
gradient energy minimization. Now, also the CK
atoms are allowed to move. In stage 2 electrostatic
interactions are introduced into the potential energy
function. The main chain atoms obtain their charges
corresponding to the PARAM19 parameter set. Par-
tial charges on side chain atoms of polar side chains
are gradually scaled up (from 0.05 to 0.4 times their
full value) during the temperature reduction from
500 to 300 K. The scaling factor 0.4 is also applied
during the 5 ps dynamics and energy minimization.
A distance dependent dielectric function is used, with
a switching function smoothly truncating distant
electrostatic interactions. In stage 2 we obtain
5U5 = 25 structures. The most symmetric structure
in respect to the pseudo 5-fold symmetry axis of
the bundle is chosen for the simulations.
Two of the models (WX-in and WX-out) are equiv-
alent to W-in and W-out in respect to the orientation
of the tryptophans: WX-in (tryptophans point into
the pore, generated by XPLOR ‘WX’) and WX-out
(tryptophans point towards the pore). A third ‘best
guess’ model is built using Xplor with all serines
facing the pore (SX-in, starting tilt angle 5‡). The
rationale for a bundle like this is based on the ¢nd-
ings in other ion channels: (i) hydrophilic residues,
such as serines, line the pore of the channel (e.g. like
in nicotinic acetylcholine receptor derived from mu-
tagenesis data [29^32]), and (ii) tryptophans are lo-
cated at a hydrophobic/hydrophilic interface (e.g.
porin [33], bacteriorhodopsin [34]).
2.2. Simulations and analysis
All ¢ve of the helix bundles were placed in
holes (approx. 6U6 nm2) within a lipid bilayer of 1-
palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylcholine
(POPC) and consequently solvated with more than
30 water molecules (SPC water model [35]) per lipid,
resulting in a system of approx. 20 000 atoms [21].
Simulations were run for 2 ns using GROMACS
1.6 software (http://rugmd0.chem.rug.nl/Vgmx/gmx.
html) on a 10 processor SGI Origin 2000 machine.
For data analysis Gromacs and DSSP [36] software
was used. The structures were visualized with the
programme MOLSCRIPT. To assess whether a
structure has reached equilibrium, the RMSD of
the CK atoms (peptide unit) are consecutively related
to structures at selected time steps, i.e. 1000 ps, 1500
ps, and 2000 ps using the protocol in [37].
3. Results
In Fig. 1 the RMSD values of all ¢ve structures
are presented. A step descent or ascent of the values
to or from the reference value indicates a non-equil-
ibrated system. W-in is not yet equilibrated during
the 2 ns simulation (Fig. 1A). WX-in (Fig. 1B) seems
to adopt an equilibrated structure: a descending
curve at the beginning of the simulation reaching a
plateau without any major descent and ascent
around the reference points. The RMSD values for
the bundle W-out (Fig. 1C) and to a slightly lesser
extend for WX-out (Fig. 1D) both reach a similar
plateau after the ¢rst half of the simulation. The
values for the ‘best guess’ model SX-in (Fig. 1E) level
o¡ after approx. 400 ps.
Table 1
Pentameric bundles of Vpu (AIV A10 LVVAIIIAI V20 VWSI-
VIIE) used in this study
W-in Structure derived from Kukol et al. [19] by FTIR
spectroscopy: all tryptophans facing the pore
WX-in Structure generated using Xplor: tryptophans
facing the pore
W-out Structure derived from Kukol et al. [19] by FTIR
spectroscopy: all tryptophans pointing towards the
lipid phase
WX-out Structure generated using Xplor: tryptophans
pointing towards the lipid phase
SX-in ‘Best guess’ model, generated using Xplor: serines
facing the pore, tryptophans are located at the
peptide/lipid/lipid-head-group interface
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3.1. Structure of the bundles
A view down the pore from the N terminus to the
C terminus of W-in and SX-in at 0 ns and 2 ns
simulation is shown in Fig. 2. In W-in the trypto-
phans completely block the pore of the bundle in the
starting structure (Fig. 2A), with the serines facing
the hydrophobic segment of the bilayer. At the end
of the simulation the situation has drastically
changed: two segments seem to escape from the as-
sembly, one segment with its C-terminal end, the
other with its N-terminal end. SX-in forms a bundle
with a slightly left-handed super coiling (Fig. 2B).
After 2 ns of simulation this coiling is still visible
and the tryptophans are located at the helix-helix/
helix-lipid interface. In addition, the serines have
moved closer to their adjacent helices. Fig. 3 shows
W-out, WX-out, and WX-in after 2 ns of simulation.
For WX-in all tryptophans remain facing the pore at
the end of the simulation.
For all bundles the tilt angle converges towards a
mean value of 15‡ (W-in: 16‡ þ 4‡, WX-in: 14‡ þ 4‡,
W-out: 11‡ þ 4‡, WX-out: 11‡ þ 4‡, SX-in: 13‡ þ 5‡).
These values are in the same order of those values
found for bundles of Vpu in a low dielectric slab
mimicking a lipid bilayer [38]. The averaged inter-
helix crossing angle (angle with which two adjacent
helices cross each other) does not show any trend for
the models under investigation (W-in: 11‡ þ 7‡, WX-
in: 14‡ þ 6‡, W-out: 14‡ þ 9‡, WX-out: 8‡ þ 4‡, SX-in:
15‡ þ 9‡). Also the average inter-helix distance re-
mains around 1.1^1.2 nm for all bundles.
3.2. Hydrogen bonding
We analysed the fraction of hydrogen bonding fH
(fH = nH/nTWq), where nH is the total number of time
steps during which the residues form hydrogen
bonds, nT the total number of time steps in the sim-
ulation, and q the number of observed hydrogen
bonds formed by the residue) of the serines and tryp-
tophans. The fraction of each residue in the individ-
ual segments of the bundles is shown in parentheses
C
Fig. 1. CK RMSD versus time calculated for reference confor-
mations at 1000 (black), 1500 (grey), and 2000 ps (light). (A)
W-in; (B) WX-in; (C) W-out; (D) WX-out; (E) SX-in.
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(see below). An explanation of the hydrogen bonding
analysis is given in more detail elsewhere [21,39].
High values of fH indicate that the residues remain
hydrogen bonded with only a few partners over the
entire simulation, low values indicating that the res-
idue is either involved in hydrogen bonding for a
short fraction of the time or that there is a high
number of changing partners for hydrogen bonding.
Some of the tryptophans in W-in form hydrogen
bonds with neighbouring segments (fH : 0.13, 0.03,
0.06). Since the tryptophans are in the pore they
also undergo hydrogen bonding with pore waters
(fH : 0.03, 0.02, 0.02, 0.03). All serines show hydrogen
bonding preferentially with carbonyl functionality of
the peptide unit (backbone) within their own segment
(fH : 0.26, 0.27, 0.18, 0.37, 0.22). Only one serine
forms hydrogen bonds with water molecules (fH :
0.07). A similar pattern is derived with the bundle
WX-in (data not shown).
For two tryptophans in SX-in hydrogen bonding
with the backbone of their neighbours is observed
(fH : 0.22, 0.07). The serines show preferential hydro-
gen bonding with the backbone of the same segment
(fH : 0.15, 0.10, 0.05, 0.07, 0.39). One serine does
show hydrogen bonding with a side chain of a neigh-
bouring segment (fH : 0.21). In addition, nearly all of
the serines form hydrogen bonds to water molecules
(fH : 0.04, 0.04, 0.03, 0.03).
The tryptophans in W-out and WX-out lack any
major hydrogen bonding (data not shown). The ser-
ines in both of these bundles interact either with the
backbone of their own segment or with a neighbour-
ing segment, although interactions with water mole-
cules are also found.
4. Discussion
Without any structure for the short TM spanning
viral peptides, it still remains an intriguing task as to
how the individual segments are orientated to form a
proper ion conducting pore [40]. A common scheme
is to orient the hydrophilic residues within a hydro-
phobic TM segment in such a way that all these
Fig. 2. Top view of the bundles. (A) W-in; (B) SX-in. In both panels at 0 ns (left) and 2 ns (right). Tryptophans and serines are
drawn in stick and ball modus. Figures are generated with MOLSCRIPT.
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residues point towards the centre of the bundle. This
would consequently restrain the position of other
residues, e.g. the tryptophans. In such an orientation
(serines facing the pore in this study) the tryptophans
are most likely located at the helix-helix and helix-
lipid head group interface. Orientation of trypto-
phans at the helix-lipid head group interface is also
experimentally con¢rmed for other ion channel pep-
tides such as gramicidin [41^44]. Tryptophans and
phenylalanines of the channel pore porin are also
located at the outer side of the protein aligned to-
wards the lipid head groups [45]. Model SX-in satis-
¢es the intention about the alignment to form ion
conducting pores of peptides or proteins. This model
places the tryptophans towards the helix-helix/helix-
lipid head group interface. The computational simu-
lations reveal that this model adopts the most stable
structure during the 2 ns simulation.
For bacteriorhodopsin tryptophans are also found
within the interior of the protein. Some of them are
essential to support proton translocation (see exam-
ples in [46^48]). In the case of M2 from in£uenza A,
alignment of Ser-31 and His-37 towards the centre of
the bundle automatically orients Trp-41 into the
same direction [49]. These tryptophans would also
occlude the pore; however, tetrameric bundles of
M2 are characterized by a large tilt or tepee-like
structure in the simulations, thereby having a wider
opening towards the C terminus [50^52]. Solid state
NMR revealed tilt angles (s 30‡ [53,54]) which are
larger than for Vpu (6 30‡ [55^57]). It seems likely
that the tryptophans contribute to the overall struc-
ture of the TM segments of in£uenza’s M2. Thus, the
Vpu model proposed by Kukol and Arkin [19] would
not be unique in respect of its tryptophan orienta-
tion. Serines and tryptophans are the only residues
capable of forming hydrogen bonds within the oth-
erwise highly hydrophobic TM segment of Vpu. This
motif (long hydrophobic segment with two adjacent
hydrophilic residues towards the C-terminal end) is
probably one of the reasons for Vpu’s conductance
of ions and insensitivity to amantadine as outlined in
[55].
A global molecular dynamics search protocol on
tetrameric, pentameric and hexameric bundles has
been used to generate clusters of possible structures
of such bundles [19]. Bundle structure W-in corre-
sponds to one cluster for which the structure coin-
cides reasonably with experimental data from FTIR
spectroscopy regarding only the pitch angle g. How-
ever, the very low tilt angle from the experiment
(6.5 þ 1.7‡ [19]) limits the possibility to obtain proper
pitch angles with spectroscopic methods (solid state
Fig. 3. Model of W-out (A), WX-out (B), and WX-in (C) after
2 ns of simulation (top view). Tryptophans and serines are indi-
cated as in Fig. 2. Lipids and water molecules omitted for
clarity.
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NMR: 6 30‡ [55^57]) as discussed in [19]. Neverthe-
less, the low energy of W-in (E =3182 kcal/mol)
from the global search analysis in the absence of
water during the calculations makes this bundle a
possible model for an energetically stable structure.
Simulations of W-in on a longer time scale and in
fully solvated lipid bilayer suggest that the segments
rotate away from each other forcing the tryptophans
between the helices and closer to the lipid head group
region. During the in vacuo simulations [19], the
tryptophans might be held together by inter-hydro-
gen bonding. The result is the ‘low energy’ structure
W-in. In the present simulation the water molecules
might compete for hydrogen bonding and conse-
quently weaken the hydrogen bonding between the
tryptophan residues. As a consequence the segments
are able to drift apart because of repulsive forces.
However, during the simulations of WX-in no ‘open-
ing’ of the channel is observed. Thus, the highly oc-
cluded pore does not necessarily repel the segments
or induce a rotational motion during the time course
of the simulation. This ¢nding re£ects again the sen-
sitivity of the results on the initial starting structure
of the peptide prior to the insertion into a bilayer
and consecutive hydration (see e.g. [58]). As a con-
clusion: it is likely that tryptophans may occlude the
pore by forming a stable assembly.
At the present stage the results of the simulations
suggest a stable ‘open-like’ structure having all the
serines facing the pore. W-in and WX-in seem to
represent a ‘closed-like’ structure. A gating mecha-
nism can be imagined by a screw-like motion of at
least one or two segments. Such rotation (screw-like
motion) of one helical TM segment is also proposed
for voltage gated Na-channels [59^61]. In the light
of our data one might assume that the di¡erence
between open and closed is controlled by conforma-
tional changes in the TM peptide assembly rather
than by movement of a single TM segment from or
to a pre-existing bundle. More sensitive experiments
with respect to the tryptophans are essential to assess
a greater conformational space before a mechanism
based on computational results can be outlined.
We are aware of the discrepancy between the tilt
angle of the TM helix in lipids derived from FTIR
spectroscopy (6.5 þ 1.7‡) and the tilt angles of the
segments obtained after 1 ns simulation (approx.
15‡). The FTIR data were collected with lipids in
the gel phase; however, the simulation was run under
conditions which correspond to a £uid phase of the
lipids. It may be possible that the gel phase of the
lipids induces a straightening of the helices.
5. Conclusion
We have tested a limited number of Vpu bundles
with respect to the orientation of the tryptophans
and serines within the TM segment. The current sam-
pling suggests an ‘open-like’ and ‘closed-like’ struc-
ture in dependence of the positions of the trypto-
phans. The simulations are sensitive to the initial
starting structure, suggesting the need of either
more extensive computational sampling of conforma-
tional space for a de novo design of the model or
further experimentally derived structural constraints
including also the extramembranous parts of Vpu.
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